HCV RNA / TMA assay (Qualitative)
RT-PCR / bDNA (Quantitative)

Triphasic Decline of Hepatitis C Virus RNA during Interferon-based Antiviral Therapy   - 8/10/07

Resiquimod Reduces HCV Viral Load, but Causes Side Effects Similar to Interferon   - 7/31/07

400,000 IU/mL Is the Optimal Baseline Viral Load Cut-off to Predict Response In Treatment-naive Patients with Genotype 1 HCV  - 4/24/07

72-Week Treatment More Effective than 48 Weeks for Patients with Detectable HCV Viral Load at Week 4   - 8/29/06

Distribution of Hepatitis C Virus Genotypes and Viral Load Levels in the U.S.   - 8/25/06

Hepatitis C Virus Detection Using HCV RNA Qualitative (TMA) Testing in the HALT-C Trial - 8/11/06

Detection of HCV RNA Using Sensitive Test Can Help Guide Therapy- 5/30/06

Differences in Outcomes of Treatment with PegIntron Plus Fixed-dose or Weight-based Ribavirin Based on Genotype and Viral Load in HCV Genotypes 2 and 3 in The WIN-R Trial - 5/23/06

Small Study Shows HCV RNA Levels Undetectable in 12 of 12 HCV Genotype 1 Patients after 4 Weeks of Treatment with Experimental HCV Drug VX 950 Plus Pegasys and Ribavirin - 2/10/06

Experimental Oral Protease Inhibitor VX-950 from Vertex Produces Rapid and Dramatic Reduction in HCV RNA in Combination with Pegylated Interferon Alfa-2a (Pegasys) - 1/10/06